“The Gold Sheet” Publishes Database of 2011 Drug Recalls
This article was originally published in The Gold Sheet
Executive Summary
A first from “The Gold Sheet” – a database of drug recalls that can be searched by company, type of problem, type of product, country of origin and other factors. Open and download a copy here.
You may also be interested in...
Contamination Issues Drove Drug Recalls to Record Levels in 2011
How contamination, sterility assurance, OOS and other issues caused drug recalls to spike again last year. What happened at Aidapak, H&P, Ben Venue, Hospira, Teva and other manufacturers to set a new record.
Emergent COVID-19 Vaccine Plant’s Quality Issues Draw Unusual Spotlight From US FDA Topsiders
Remediation must be quick and sure, say FDA’s Woodcock and Marks, despite challenges with facilities, equipment, processes and personnel training.
Emergent Suspends COVID-19 Vaccine API Manufacturing As US FDA Inspects Bayview Plant
After discovery of viral vector cross-contamination, AstraZeneca quit, J&J took control and the FDA launched inspection.